Author

Uyen M. Vu

Institution: The University of Texas MD Anderson Cancer Center

Observed institution: The University of Texas MD Anderson Cancer Center

OpenAlex ID: A5111162953

Abstract CT289: A phase II study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in patients with HER2-positive metastatic solid tumors and metastases to brain (TUCATEMEB)

2024 · Ecaterina E. Dumbrava, Amber M. Kennon, et al. · Cancer Research

Abstract CT292: Phase II study of pembrolizumab in combination with lenvatinib in patients with triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and other tumor types and brain metastases

2024 · Ecaterina E. Dumbrava, Emma J. Montazari, et al. · Cancer Research

Works count: 2

Citation count:

H-index:

I10-index: